Clinical Trials Directory

Trials / Completed

CompletedNCT02252744

Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis

Status
Completed
Phase
Study type
Observational
Enrollment
286 (actual)
Sponsor
Western University of Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.

Detailed description

We investigated the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis by information sheets and direct recruitment of patients of potential study participants diagnosed with rheumatoid arthritis. Subjective assessment for dry eye disease was performed using Ocular Surface Disease Index (OSDI) questionnaire. The following objective tests of dry eye disease were employed: tear osmolarity (TO), tear break-up time (TBUT), corneal fluorescein staining score and conjunctival lissamine green staining scores using the National Eye Institute-recommended grading system, and Schirmer without anesthetic. The Dry Eye Severity Grading Scheme highlighted by the Dry Eye WorkShop was adapted to quantify dry eye disease severity level.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2012-11-01
Primary completion
2014-06-01
Completion
2014-12-01
First posted
2014-09-30
Last updated
2016-02-03
Results posted
2016-02-03

Source: ClinicalTrials.gov record NCT02252744. Inclusion in this directory is not an endorsement.